U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 2114

1.
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials
J. Taieb, F. A. Sinicrope, L. Pederson, S. Lonardi, S. R. Alberts, T. J. George, G. Yothers, E. Van Cutsem, L. Saltz, S. Ogino, R. Kerr, T. Yoshino, R. M. Goldberg, T. André, P. Laurent-Puig, Q. Shi
Ann Oncol. Author manuscript; available in PMC 2024 Mar 14.
Published in final edited form as: Ann Oncol. 2023 Nov; 34(11): 1025–1034. Published online 2023 Aug 23. doi: 10.1016/j.annonc.2023.08.006
PMCID:
PMC10938565
ArticlePDF–1.3M
2.
Cancer: slaying the nine-headed Hydra
J. J. Adashek, V. Subbiah, C. B. Westphalen, A. Naing, S. Kato, R. Kurzrock
Ann Oncol. Author manuscript; available in PMC 2024 Mar 8.
Published in final edited form as: Ann Oncol. 2023 Jan; 34(1): 61–69. Published online 2022 Aug 2. doi: 10.1016/j.annonc.2022.07.010
PMCID:
PMC10923524
ArticlePDF–851K
3.
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Guillermo Villacampa, Nadine M. Tung, Sonia Pernas, Laia Paré, Coralia Bueno-Muiño, Isabel Echavarría, Sara López-Tarruella, Marta Roche-Molina, María del Monte-Millán, Mercedes Marín-Aguilera, Fara Brasó-Maristany, Adrienne G. Waks, Tomás Pascual, Olga Martínez-Sáez, Ana Vivancos, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci, Gaia Griguolo, Javier Cortés, Antonio Llombart-Cussac, Montserrat Muñoz, Maria Vidal, Barbara Adamo, Antonio C Wolff, Angela DeMichele, Patricia Villagrasa, Joel. S. Parker, Charles M. Perou, Aranzazu Fernandez-Martinez, Lisa A. Carey, Elizabeth A. Mittendorf, Miguel Martín, Aleix Prat, Sara M. Tolaney
Ann Oncol. Author manuscript; available in PMC 2023 Dec 21.
Published in final edited form as: Ann Oncol. 2023 Sep; 34(9): 783–795. Published online 2023 Jun 9. doi: 10.1016/j.annonc.2023.05.012
PMCID:
PMC10735273
ArticlePDF–1.1M
4.
Treatment of evolving cancers will require dynamic decision support
M. A. R. Strobl, J. Gallaher, M. Robertson-Tessi, J. West, A. R. A. Anderson
Ann Oncol. Author manuscript; available in PMC 2023 Nov 30.
Published in final edited form as: Ann Oncol. 2023 Oct; 34(10): 867–884. doi: 10.1016/j.annonc.2023.08.008
PMCID:
PMC10688269
ArticlePDF–1.0M
5.
Evaluation of the Change of Outcomes over a Ten-Year Period in Patients with Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated with Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database
M. E. Salem, J. Yin, R. M. Goldberg, L. D. Pederson, N. Wolmark, S. R. Alberts, J. Taieb, J. L. Marshall, S. Lonardi, T. Yoshino, R. S. Kerr, G. Yothers, A. Grothey, T. Andre, A. De Gramont, Q. Shi
Ann Oncol. Author manuscript; available in PMC 2023 Nov 30.
Published in final edited form as: Ann Oncol. 2020 Apr; 31(4): 480–486. Published online 2020 Jan 16. doi: 10.1016/j.annonc.2019.12.007
PMCID:
PMC10688027
ArticlePDF–1.0M
6.
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S. J. Luen, G. Viale, S. Nik-Zainal, P. Savas, R. Kammler, P. Dell’Orto, O. Biasi, A. Degasperi, L. C. Brown, I. Láng, G. MacGrogan, C. Tondini, M. Bellet, F. Villa, A. Bernardo, E. Ciruelos, P Karlsson, P. Neven, M. Climent, B. Müller, W. Joshum, H. Bonnefoi, S. Martino, N. E. Davidson, C. Geyer, S. K. Chia, J. N. Ingle, R. Coleman, C. Solbach, B. Thürlimann, M. Colleoni, A. S. Coates, A. Goldhirsch, G. F. Fleming, P. A. Francis, T. P. Speed, M. M. Regan, S. Loi
Ann Oncol. Author manuscript; available in PMC 2023 Nov 1.
Published in final edited form as: Ann Oncol. 2023 Apr; 34(4): 397–409. Published online 2023 Jan 25. doi: 10.1016/j.annonc.2023.01.009
PMCID:
PMC10619213
ArticlePDF–1.7M
7.
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
P. Selenica, A. Marra, N.J. Choudhury, A. Gazzo, C.J. Falcon, J. Patel, X. Pei, Y. Zhu, C.K.Y. Ng, M. Curry, G. Heller, Y-K. Zhang, M.F. Berger, M. Ladanyi, C.M. Rudin, S. Chandarlapaty, C.M. Lovly, J.S. Reis-Filho, H.A. Yu
Ann Oncol. Author manuscript; available in PMC 2023 Dec 1.
Published in final edited form as: Ann Oncol. 2022 Dec; 33(12): 1284–1295. Published online 2022 Sep 9. doi: 10.1016/j.annonc.2022.09.151
PMCID:
PMC10360454
ArticlePDF–1.8M
8.
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small cell lung cancer
L. Federico, D. J. McGrail, S-E. Bentebibel, C. Haymaker, A. Ravelli, M-A. Forget, T. Karpinets, P. Jiang, A. Reuben, M. V. Negrao, J. Li, R. Khairullah, J. Zhang, A. Weissferdt, A. A. Vaporciyan, M. B. Antonoff, G. Walsh, S-Y. Lin, A. Futreal, I. Wistuba, J. Roth, L. A. Byers, P-O. Gaudreau, N. Uraoka, A. F. Cruz, H. Dejima, R. N. Lazcano, L. M. Solis, E. R. Parra, J. J. Lee, S. Swisher, T. Cascone, J. V. Heymach, J. Zhang, B. Sepesi, D. L. Gibbons, C. Bernatchez
Ann Oncol. Author manuscript; available in PMC 2023 Mar 16.
Published in final edited form as: Ann Oncol. 2022 Jan; 33(1): 42–56. Published online 2021 Oct 13. doi: 10.1016/j.annonc.2021.09.021
PMCID:
PMC10019222
ArticlePDF–2.5M
9.
Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine
K. Ding, F. Chen, N. Priedigkeit, D.D. Brown, K. Weiss, R. Watters, K.M. Levine, T. Heim, W. Li, J. Hooda, P.C. Lucas, J.M. Atkinson, S. Oesterreich, A.V. Lee
Ann Oncol. Author manuscript; available in PMC 2023 Oct 1.
Published in final edited form as: Ann Oncol. 2022 Oct; 33(10): 1085–1088. Published online 2022 Jun 25. doi: 10.1016/j.annonc.2022.06.005
PMCID:
PMC10007959
ArticlePDF–736K
10.
Deciphering radiological stable disease to immune checkpoint inhibitors
J. Luo, S. Wu, H. Rizvi, Q. Zhang, J.V. Egger, J.C. Osorio, A.J. Schoenfeld, A.J. Plodkowski, M.S. Ginsberg, M.K. Callahan, C. Maher, A.N. Shoushtari, M.A. Postow, M.H. Voss, R.R. Kotecha, A. Gupta, R. Raja, M.G. Kris, M.D. Hellmann
Ann Oncol. Author manuscript; available in PMC 2023 Aug 1.
Published in final edited form as: Ann Oncol. 2022 Aug; 33(8): 824–835. Published online 2022 May 6. doi: 10.1016/j.annonc.2022.04.450
PMCID:
PMC10001430
ArticlePDF–1.2M
11.
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
H.J. Burstein, G. Curigliano, B. Thürlimann, W.P. Weber, P. Poortmans, M.M. Regan, H.J. Senn, E.P. Winer, M. Gnant, Panelists of the St Gallen Consensus Conference
Ann Oncol. 2021 Oct; 32(10): 1216–1235. Published online 2021 Jul 6. doi: 10.1016/j.annonc.2021.06.023
PMCID:
PMC9906308
ArticlePDF–840K
12.
Association of Tumor-infiltrating Lymphocytes (TILs) with Survival Depends on Primary Tumor Sidedness in Stage III Colon Cancers (NCCTG N0147) [Alliance]
B. Saberzadeh-Ardestani, N. R. Foster, H. E. Lee, Q. Shi, S. R. Alberts, T. C. Smyrk, F. A. Sinicrope
Ann Oncol. Author manuscript; available in PMC 2023 Nov 1.
Published in final edited form as: Ann Oncol. 2022 Nov; 33(11): 1159–1167. Published online 2022 Aug 10. doi: 10.1016/j.annonc.2022.07.1942
PMCID:
PMC9882989
ArticlePDF–979K
13.
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study
Z. R. Reichert, T. M. Morgan, G. Li, E. Castellanos, T. Snow, F. G. Dall’Olio, R. W. Madison, A. D. Fine, G. R. Oxnard, R. P. Graf, D. G. Stover
Ann Oncol. Author manuscript; available in PMC 2023 Jan 1.
Published in final edited form as: Ann Oncol. 2023 Jan; 34(1): 111–120. Published online 2022 Oct 5. doi: 10.1016/j.annonc.2022.09.163
PMCID:
PMC9805517
ArticlePDF–1.5M
14.
428P Clinical characteristics, laboratory parameters, and hospital outcomes of COVID-19 among patients with and without cancer: A retrospective cohort study
P. Sirohiya, H.K. Raju Sagiraju, M. Baruah, R. Singh, A. Elavarasi, S. Vig, B.K. Ratre, B. Kumar, A. Pandit, S. Bhatnagar
Ann Oncol. 2022 Nov; 33: S1607–S1608. Published online 2022 Dec 4. doi: 10.1016/j.annonc.2022.10.459
PMCID:
PMC9719678
ArticlePDF–226K
15.
286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
A. Body, E.S. Ahern, L. Lal, H. Abdulla, S. Opat, P. Downie, M. Leahy, N. Fuentes-Bolanos, B. Padhye, N. Hamad, V. Milch, E. Segelov
Ann Oncol. 2022 Nov; 33: S1544. Published online 2022 Dec 4. doi: 10.1016/j.annonc.2022.10.312
PMCID:
PMC9719676
ArticlePDF–169K
16.
244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience
P. Singh, D.M. Joseph, A.S. Krishnan, R. Ahuja, S. Gupta, M. Gupta
Ann Oncol. 2022 Nov; 33: S1528–S1529. Published online 2022 Dec 4. doi: 10.1016/j.annonc.2022.10.279
PMCID:
PMC9719674
ArticlePDF–199K
17.
444P Incidence of cancer diagnosis and cancer care before and after the COVID-19 pandemic in French Polynesia TEAHUPOO study
E. Hirigoyen, N. Epaillard, M. Chastenet, R.A. Herve, J-P. Dutin, P. Gustin, L. Mahjoubi
Ann Oncol. 2022 Nov; 33: S1612. Published online 2022 Dec 4. doi: 10.1016/j.annonc.2022.10.474
PMCID:
PMC9719672
ArticlePDF–160K
18.
453P Relationship between Interleukin-6 Levels (IL-6) and COVID-19 vaccination status in cancer patients at Dr. Moewardi General Hospital, Indonesia
R.A. Hutabarat, W. Soewoto
Ann Oncol. 2022 Nov; 33: S1615. Published online 2022 Dec 4. doi: 10.1016/j.annonc.2022.10.483
PMCID:
PMC9719670
ArticlePDF–163K
19.
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients
A. Pradier, AC. Mamez, C. Stephan, F. Giannotti, S. Masouridi-Levrat, S. Wang, S. Morin, D. Neofytos, D.L. Vu, A. Melotti, I. Arm, C.S. Eberhardt, J. Tamburini, L. Kaiser, Y. Chalandon, F. Simonetta
Ann Oncol. 2022 Dec; 33(12): 1333–1335. Published online 2022 Sep 16. doi: 10.1016/j.annonc.2022.09.153
PMCID:
PMC9477612
ArticlePDF–679K
20.
1340P Trends in access to early phase clinical trials in underserved populations during the COVID-19 pandemic
J. Balmaceda, D.P. Mudaranthakam, G. Doolittle, W. Sun, H. Krebill, T. Lin, A. Jewell, A. Saeed, S. Abbasi, R. Jensen, J.C. Baranda
Ann Oncol. 2022 Sep; 33: S1153. Published online 2022 Sep 13. doi: 10.1016/j.annonc.2022.07.1472
PMCID:
PMC9472790
ArticlePDF–156K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center